ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001197.1|Frankiamicin_1 # 1 # 3399 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.718	BGC0001197.1|Frankiamicin_1 	1	3399	+	Loose	890	33.8834	cpxA	22.22	3000830	protein homolog model	n/a	n/a	aminoglycoside antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTCCGGAATTGGCCCATCCGCTCGAAGCTAGTGGTGATTCTCATCGTCCCGCTGGCCGCGCTGGCCGTGCTGAGCGCGATACAGGTGCGCGGGGACGTCGACAACGTCCGGGCCGCGGGCCGCATCGAGGCGCTCGCCGACTTCTCGATCAAAGGTAACAACCTGGTCCACGTGCTTCAGCGGGAGCGCTATGCGACCAACTCTTACGTTGGATCGAACTTCCTCATCCCGATGCTGGGCCAGCAGGCTGTGGATGCCCGCAAGCCCGTGGACGACGCCCTCGCCATCTACCTGGCCGACGAGCAGGCACTGCCCGCGTCCGCGCGCGACGCCCTCGGCTCGACACTGAGTTCCATCCGTACGCATCTCGACCAGCTCGGCGAGCACCGCAAGCAGATCGACGCGCACCAGACCGAGATCGCGTCGAACGGGGCCTTCTACAACGAGGCCGTGAACGAGCTGCTGCTGCTCAACGCGCGGATCGCGGCCGGTAGCTCGGACGCCAAGCTGGTCAACGGCTCTACCACGCTGGCCGGTATCGCCCAGGCCAAGGAACAAGCCTCCCAGCAGCGTGGATCCGTCGCCCAGATGCTCTCCATGGGCAACCCCACGCCGCAGATGCTGCGTGCTCTGCTGGCCTACGCCGGTGCCGAGACCGCCTGGACCGAGCAGTTCCGCTCCACGGCGACGCCGGCCGAGCTGGAGCTGTTCACGAACACGGTCGGGCGCTCTGCCACCGGCGTCAACCAGATGCGCGACGACGTGGTCAACAGGTTCAGCGGGCAGCAGGCTCCCGACGTCGGCCTCGAGGCCTGGCGGACCGCCGCCGACAGCAAGATCGCGCAGATGCACGACGTCGAGGTGCAGATCGCCAACGACCTGGCGGCGACAAGTCGCGACATCGCCTCGACGGCCTCCCGGGACGCCCTGCTCGGAAGCATCGGCGTGGCGATCATTCTCGTGCTCTCGGTCGTGATCTCACTGCTCGTCGCGAGCCCCATGATCGGTCAGCTCCGCCGGCTGCGGGGTGGCGCGCTCGACGTCGCCAACGACCGGCTGCCCAGCGTCGTCGAGCGGCTGCACCGGGGTGAGCCCGTCGACATCGACGCGGAGTCCTTCCCGGTACCCGCGACCAGCAAGGACGAGATCGGCCAGCTGGCGGAGGCGTTCGCCACGGTGCACGAGGTGGCGGTGCGCACCGCCGTCGAGCAGGCCGCGATGCGCAAGAGCATCGGGGACACCTTCCTCAACCTCGCGCGCCGCAGCCAGGCCCTGATCCACCGCCAGCTGAAGATCATTGACGCGCTGGAGCGCAAGGAGACCGACCCGGACGAGCTCGAGGAGCTGTTCCGGCTCGACCACCTCGCGACCCGTATGCGGCGCCACGCCGAGGACCTCATCGTCCTCTCCGGCTCCAAGCCCGCCCGTGGCTGGCGCCGGCCGGTTCCGATCAAGGACGTCGTCCGCGGTGCCGTCGCCGAGGTCGAGGACTACACCCGGGTCAAGGTCCTGCCCATCACCGGTGGCGCCGTCTCCGGCCACGCCGTCGGTGACGTGATCCACATGTTCGCCGAGCTGATCGAGAACGCGACCTCCTTCTCGCCCCCGCACACCCCCGTGCAGGTCGCCGGGCACCCGGTCTCCAACGGCTTCGTGGTCGAGATCGAGGACCGCGGGCTCGGGATGAACCAGGAGGAGATCGACGCGCTCAACAACCGGCTGGCGAACCCGCCGCCGTTCGACCTGTCGACCAGCGAGCGGCTGGGCCTGTTCGTGGTCAGCCGGCTGGCGGAGCGGCACGACGTCCAGGTACGGCTGCGGCCGTCGCCGTACGGCGGCACGATGGCGATCGTCCTGCTGCCCGCGACCCTGCTGCGCGCCTCCGACGACAAGGGCGAGGACAGCGGCCCGCGCGAGTTCGCCGCGGTCGGCGCGTCGAGCGTCGGCGCCCAGGGCTCGGACCTGGCCGGCTCGCTCAACGGCACCAGCGAGCGGGTGGGGGCCGGCGCGTCCGGCCCGGAGAGCAACGGCCACTGGGCGGGAAACATCCCCGGGGACACCCTGGACGCGGCGGCGCTGTCGACGGCCGGAGCCGTCAACGGTGCCGGCCCCAGCACCGACGAGACGCTGATCGACGACCTCCCGGTCTTCGCCACGGCGCGGTCGAGCTGGTTCGTGGCGGAGAAGCCCCGTGGCAGGAACCGGACAGACGACGAGGGGGACGACGACGGGCCGATCCCGCCGCGCCGCCCCGGCGAGCTGACCGGTCCGACGCGGCGGGCCGAGCTCCCGCCGTCCCAGGACGGAGCCGGCTACCCGGAGGACTCGGGGGACGCGGGCTGGTCCGACGGACGGTCCGACCCGTCGGCCTCACTGTTCGGCCCGCCTCCGGGCGGCGGCGAGTTCGGCGGCTCGCTGTTCAGCGCTCCGCCTGACACCGGTCAGTTCAGCGGCTTCGGTCCGAACGGCTTCGGTGACGGCGGCGGCTACGGTGACGCGGGCTTCGGTGACAGCGGCGGCTACGCCGGCGGCTTCGGTGGCGGCGCGACCGATGTCGGCGCCAACGGCATGGCCGGCAACGGATCGGGTGGCTTCGCTGACTCGGATTACCACACCGCCGAGTTCAGCCGGTCCGGTTTCGGCACCGGCGGCGGCTTCGGGAACGACAGCGGTCACGGGAACGACGGCGGTCACGGGAACGACGGCGGTCCCGGGAACGACGGCGGCCTGGGGCAGGAGACCGGCGACGGCTTCGGCTCGGCCGGTGGTTTCGGTTCGGGTGACGGCTTCGGTTCGGCTGACTCCCAGCCCGGGGCCGGGCTGCCGTCCCGCTCCCGGACCGGGCGGGCCTCGGGCGACTACGCCCGCGCCGACTACACGCCACCGGGCCAGCAGGGCCCGGCCGGGGACGGGACCGGCTACCGCGAGCCCCGCGCGGACCGCGGCCAGGAATTCGGCCGTCCCATGCGGGAGAACGGGTACGGCGGGGCGGAACAGGCCTACCCCGGACGCCAGGACGGCGGCATCGGCGACGGCGCCTTCCGCCGCTCGGCCCGGTCGTCGCACCCGGGGCAGTCCACCGGTGGGGGCTCCGCCTACCCCGGGGCCAACCCGCCGCCGGCGGCGCCGCCGTTCGACACGGCAGCCGCCGCGGCGGAGGAGTCCGCCGACGACGGTCTCGACGAGCTCGGCCTGCCCAAGCGGCGGCGGCGCGCGAACCTGGCGCCGCAGCTGCGCCGGGAGAACGCGGACGCGGGCCGTTCGTCGCTCGCCGCGGGCCCTCGTTCACCCGAGGAGATCCGCAGCATGATGTCGTCCTTCCAGGCCAACTTCGGCCGTGGGATTGAGGACGGAACGGTGTCCAATGACGGAGATGATGTGAGGAAGGTAACCTGA	MLRNWPIRSKLVVILIVPLAALAVLSAIQVRGDVDNVRAAGRIEALADFSIKGNNLVHVLQRERYATNSYVGSNFLIPMLGQQAVDARKPVDDALAIYLADEQALPASARDALGSTLSSIRTHLDQLGEHRKQIDAHQTEIASNGAFYNEAVNELLLLNARIAAGSSDAKLVNGSTTLAGIAQAKEQASQQRGSVAQMLSMGNPTPQMLRALLAYAGAETAWTEQFRSTATPAELELFTNTVGRSATGVNQMRDDVVNRFSGQQAPDVGLEAWRTAADSKIAQMHDVEVQIANDLAATSRDIASTASRDALLGSIGVAIILVLSVVISLLVASPMIGQLRRLRGGALDVANDRLPSVVERLHRGEPVDIDAESFPVPATSKDEIGQLAEAFATVHEVAVRTAVEQAAMRKSIGDTFLNLARRSQALIHRQLKIIDALERKETDPDELEELFRLDHLATRMRRHAEDLIVLSGSKPARGWRRPVPIKDVVRGAVAEVEDYTRVKVLPITGGAVSGHAVGDVIHMFAELIENATSFSPPHTPVQVAGHPVSNGFVVEIEDRGLGMNQEEIDALNNRLANPPPFDLSTSERLGLFVVSRLAERHDVQVRLRPSPYGGTMAIVLLPATLLRASDDKGEDSGPREFAAVGASSVGAQGSDLAGSLNGTSERVGAGASGPESNGHWAGNIPGDTLDAAALSTAGAVNGAGPSTDETLIDDLPVFATARSSWFVAEKPRGRNRTDDEGDDDGPIPPRRPGELTGPTRRAELPPSQDGAGYPEDSGDAGWSDGRSDPSASLFGPPPGGGEFGGSLFSAPPDTGQFSGFGPNGFGDGGGYGDAGFGDSGGYAGGFGGGATDVGANGMAGNGSGGFADSDYHTAEFSRSGFGTGGGFGNDSGHGNDGGHGNDGGPGNDGGLGQETGDGFGSAGGFGSGDGFGSADSQPGAGLPSRSRTGRASGDYARADYTPPGQQGPAGDGTGYREPRADRGQEFGRPMRENGYGGAEQAYPGRQDGGIGDGAFRRSARSSHPGQSTGGGSAYPGANPPPAAPPFDTAAAAAEESADDGLDELGLPKRRRRANLAPQLRRENADAGRSSLAAGPRSPEEIRSMMSSFQANFGRGIEDGTVSNDGDDVRKVT	MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTTEGRVIGAERSEMQIIRNFIGQADNADHPQKKKYGRVELVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSTPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTSQQRLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAQRLDSMINDLLVMSRNQQKNALVSETIKANQLWSEVLDNAAFEAEQMGKSLTVNFPPGPWPLYGNPNALESALENIVRNALRYSHTKIEVGFAVDKDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVETAIQQHRGWVKAEDSPLGGLRLVIWLPLYKRS	247.70	gnl|BL_ORD_ID|131|hsp_num:0	152			783	1356	novobiocin
BGC0001197.1|Frankiamicin_2 # 3399 # 3818 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.645	BGC0001197.1|Frankiamicin_2 	3399	3818	+	Loose	450	23.483	BlaB-39	36.0	3005552	protein homolog model	n/a	n/a	carbapenem; penam	antibiotic inactivation	BlaB beta-lactamase	ATGCGTCCGCTGGGGCCGTCGGAGAACATGAACTGGTTGCTCAACAACCTGGTCAAGAAGGTCCCCGAGGTCACCTATGTGATCGTGCTTTCTTCGGACGGTCTGCTGCTTGCGACCTCGCGTGGAATGGACCGGGCCACCGCTGACCAGCTCGCCGCGGTGGCGTCCGGATTCAACAGCCTCGCCCGGGGCGCCGGCCGGTTCTTCGGCGGCGGTAACGTTCGGCAGACCATCGTCGAGATGGAGGCGGGATTCCTGTTCGTCACCGCGGTCGGTGACGGCTCGTGCCTGGCTATTCTCAGCAGCCCGGGCGCGGATATCGGTCTCATCGCCTACGAGATGGCGCTGCTGGTGACGAGGGTGGGTGAGTTTCTGACGCCGGAGCTTCGCGCCGAAATGCAGTCGGCGCTGCCGATTTAG	MRPLGPSENMNWLLNNLVKKVPEVTYVIVLSSDGLLLATSRGMDRATADQLAAVASGFNSLARGAGRFFGGGNVRQTIVEMEAGFLFVTAVGDGSCLAILSSPGADIGLIAYEMALLVTRVGEFLTPELRAEMQSALPI	MMKGLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTDKGVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLGYFGKLGAKTYSTKMTDSILAKENKPRAKYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCIVKSGDSKDLGFIGEAYVNNWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISEYQQKQKASN	55.82	gnl|BL_ORD_ID|3331|hsp_num:0	4400			597	672	
BGC0001197.1|Frankiamicin_3 # 3936 # 4307 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.683	BGC0001197.1|Frankiamicin_3 	3936	4307	+	Loose	500	24.6386	LCR-1	38.0	3002997	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	LCR beta-lactamase	GTGTCAGGGGATGAGGAATGGTTCGACGACGAGGCCGGGCCGGTGGTGAGGCCCTACGCCGTCACGGGGGGGCGCACCCGTCCCAGTAACCGGACCCTGGATCTGGTGGCCCTGGTGTCCACCTCTCCGCAGGGGCGGGCCATCGCGACCACGCTGGAACCGGAGCAGCGTGCCATAGCGGTGCTCTGCCAGCGGCTCCAGTCCGTCGTCGAGATCTCCGCCCGACTCAACCTCCCAGTCGGCGTGGCACGTGTGCTCGTCGGCGACATGCTCGACGCCGGGCTGGTGAGTGTGCACCGGCCCGAACGAACGTCGGACCGCCCCAGCGTGGCGATTATCGAAAAGGTGCTCAGTGGACTCCAGGCTCTCTAG	MSGDEEWFDDEAGPVVRPYAVTGGRTRPSNRTLDLVALVSTSPQGRAIATTLEPEQRAIAVLCQRLQSVVEISARLNLPVGVARVLVGDMLDAGLVSVHRPERTSDRPSVAIIEKVLSGLQAL	MLKSTLLAFGLFIALSARAENQAIAKLFLRAGVDGTIVIESLTTGQRLVHNDPRAQQRYPAASTFKVLNTLIALEEGAISGENQIFHWNGTQYSIANWNQDQTLDSAFKVSCVWCYQQIALRVGALKYPAYIQQTNYGHLLEPFNGTEFWLDGSLTISAEEQVAFLRQVVERKLPFKASSYDSLKKVMFADENAQYRLYAKTGWATRMTPSVGWYVGYVEAKDDVWLFALNLATRDANDLPLRTQIAKDALKAIGAFPTK	47.31	gnl|BL_ORD_ID|829|hsp_num:0	901			72	222	
BGC0001197.1|Frankiamicin_4 # 4288 # 4911 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.671	BGC0001197.1|Frankiamicin_4 	4288	4911	+	Loose	800	25.0238	msrA	43.48	3000251	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target protection	msr-type ABC-F protein	GTGGACTCCAGGCTCTCTAGGACCCGAGCGGCCGATACACCGGCGCCGCATCCGGTAAAGATCATCGTTGCCGGTGGTTTCGGAGTCGGGAAGACGACGTTCGTCGGCGCCGTGAGCGAGATTCCCCCGCTCACCACCGAGGCCGCGATGACGTCCGCGAGTATCGGTGTTGACGACACCAGCGCCGTCGCCTCCAAGACGACGACGACGGTGGCCATGGACTTCGGTCGAATCACCCTGGTCGACAGCGTGATTCTCTACCTGTTCGGGACCCCCGGCCAGGACCGCTTCTGGTTCATGTGGGACGAACTCGTCCTGGGTGCGATCGGCGCGATCGTGCTCGTCGACACCCGACGTCTCGCCGACTCGTTTCCCGCCATCGACTACTTCGAGGAACGTGACATCCCGTTCCTCATCGCCCTGAACCACTTCGAGGGCGCGCGCCGTTACCGCAGCGAGGACATCCGCGCGGCGCTGGACCTCGACCCCCGCCGGCCGATGGTGCTGTGCGACGCCCGCCAGCGGGAGTCGGTGCGCCAGTCGCTCATCGCGTTGGTCCGCCACGCCCTGGAGGTGGTCTCCGCGGAGAGCCAGCGACCGGGACTGCCGACCGGCTCACGGTGA	MDSRLSRTRAADTPAPHPVKIIVAGGFGVGKTTFVGAVSEIPPLTTEAAMTSASIGVDDTSAVASKTTTTVAMDFGRITLVDSVILYLFGTPGQDRFWFMWDELVLGAIGAIVLVDTRRLADSFPAIDYFEERDIPFLIALNHFEGARRYRSEDIRAALDLDPRRPMVLCDARQRESVRQSLIALVRHALEVVSAESQRPGLPTGSR	MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT	42.42	gnl|BL_ORD_ID|1105|hsp_num:0	1200			963	1032	erythromycin; quinupristin
BGC0001197.1|Frankiamicin_6 # 6305 # 6682 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.667	BGC0001197.1|Frankiamicin_6 	6305	6682	+	Loose	1500	25.0238	rphA	34.38	3000444	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	GTGCCGACGGAATCCGGCTCGGTTCCGAACCAACGCACGACCAGCCAGCGGACGCTGATTGTCGCCCGGATGAACCCCGAAGACGCTGGTGCGGTCGCCGACGTCTTCGCGGAGTCGGACGCCGGCGAGCTTCCACATCTCGTCGGCGTCGCCCGGCGCGACCTTTTCCGTTTCCACGGGCTGTACTTCCATCTCATCGAGAGCCGGGCGGACATCAACGGCACGCTGCCGCCGGTTCGGGAGCACCCGCTGTTCGTCGACGTGAACAGCAAGCTCGAGAAGTACATCGCGGCGTACGACCCGCAGACCTGGCGCGGCCCCCGGGACGCGATGGCCGACAGTTTCTACACCTGGGTGGCCGATCAGAACGGTCCCTGA	MPTESGSVPNQRTTSQRTLIVARMNPEDAGAVADVFAESDAGELPHLVGVARRDLFRFHGLYFHLIESRADINGTLPPVREHPLFVDVNSKLEKYIAAYDPQTWRGPRDAMADSFYTWVADQNGP	MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS	14.45	gnl|BL_ORD_ID|890|hsp_num:0	910			1599	1788	rifampin; rifaximin; rifabutin; rifapentine
BGC0001197.1|Frankiamicin_7 # 7083 # 7340 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.686	BGC0001197.1|Frankiamicin_7 	7083	7340	+	Loose	740	24.6386	tet(30)	27.27	3000561	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCCCTGCAGTGGACCGCCGACGAGCTTCTCGACTTCCTCGTGGAGCAGGCCGGCCTGCCGCCGGAGGACCGTCCGGCCGAACTCGGCGTGACGTTCACCGACATCGGTCTGGACTCGCTCGCCTACCTGCAGCTCCAGGCCGAGGTACAGGAGCGGTTCGGCGTCGACCTGCCGAACGAGGCGCCGGAGGGATACACCCTCGCCGACATCCTCACCACGGTGAACAGCGCGCTCCTGCAGTCCGAGGTCGCCTGA	MPLQWTADELLDFLVEQAGLPPEDRPAELGVTFTDIGLDSLAYLQLQAEVQERFGVDLPNEAPEGYTLADILTTVNSALLQSEVA	MNKALIVILSTVALDAIGAGLIFPILPDILVEVTGGGDIGFLYGVMLGVFAVMQFVFSPILGALSDRFGRRPVLLLSLAGTLLDYLVMAFSPLGWVLVVGRAMAGITSANMAVASAYITDITPAEQRAQRFGTVGAVMSLGFIIGPVIGGVIGAWWLRAPFLVAALFNGLNLFVALFVLPESRKAGPGKFAFKELNPLAPLVWLWNFKPLLPLVTVSVVFGLVAAIPGTIWVLYGAERFGWDSVHMGLSLSVFGVSGALAQAFLVGPLSRRFGDLGTLMIGVGFDMLAYMLMAFANQSWMGYAVAPLFALGGVAMPALQSLVTSRVSDDQQGQLQGVLASLMSLAGIIGPVLTTAVFFSTKSIWIGTIWLVGAALYLLALPLFATVKTPKAVAA	21.57	gnl|BL_ORD_ID|1790|hsp_num:0	1917			798	966	tetracycline
BGC0001197.1|Frankiamicin_9 # 7896 # 8318 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.716	BGC0001197.1|Frankiamicin_9 	7896	8318	+	Loose	300	25.0238	AAC(3)-Ic	28.85	3002531	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	GTGAGCATCGCAACCCCCGCACCCCTGACGGTCCCCAAGGTCCTCTCGATCCACGACGTGCCGGCCAACCGGCGCCGCGGCGGTGACATCCGCACGCTGCTGTCCCCGGCGACCGTCGGCGCCAAGTCCGGCTTCCTGGGAACTCTCACCCTGCAGCCCGGCGAGGTGGTGACCGAGCACTGGCACCCCTACTCCGAGGAGTTCCTCTACTGCGTCACCGGCGCGGTCACGGCCCGCCTCGACGGCGAGCACACCGCCCTGCCGGCCGAGCACGGCCTGCTCATCCCGATCGGCATGCGGCACCGGATCGTGAACACCGGCGACGACGTGGCCTTCCTCGTCTTCCACCTCAGCCCGCTCGCGCCGCGGCCCGACCTGGGGCACGTGGACACCGAGCCGCTGCCTGAGCAGTCGCAGCAGTGA	MSIATPAPLTVPKVLSIHDVPANRRRGGDIRTLLSPATVGAKSGFLGTLTLQPGEVVTEHWHPYSEEFLYCVTGAVTARLDGEHTALPAEHGLLIPIGMRHRIVNTGDDVAFLVFHLSPLAPRPDLGHVDTEPLPEQSQQ	MISTQTKITRLNSQDVGVMRAMLGMFGEAFEDAENYCRAQPSDSYLQDLLCGSGFIAIAALQGQEVIGGLAAYVLPKFEQQRKEIYIYDLGVQGAYRRRGIATALINELQRIAHDIGAYVIFVQADYGDDPAVALYTKLGIREDVMHFDIEPQPAA	89.74	gnl|BL_ORD_ID|1035|hsp_num:0	1131			156	462	astromicin; sisomicin; gentamicin
BGC0001197.1|Frankiamicin_11 # 9664 # 10950 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.769	BGC0001197.1|Frankiamicin_11 	9664	10950	+	Loose	750	117.857	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	32.08	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGACCGTCCTCGACACCGCGCCGTCCGGGACGGCCGGCCCGGCCCGGCCGGCCGCGGGCGCGGTGCGGCCGGTCATCACCGGGCTCGGGGTCATCGCGCCCAGCGGGGTGGGCCTCGACGCGTACTGGGCCTCGACGCTGCGCGGCGAGCTGCGCGTCGCGCCGATCACCCGCTTCGACGCGAGCCGCTACGACACCCGGATCGCCGGCGAGGTCCCCGACTTCGCCGCCGAGGAGTTCGTCGACCACCGCTACCTCGTGCAGACCGACCGCTGGACCTGGATGGGCATGGCCGCGTCCAAGCTGGCGCTGGCCGACGCAGCCTACGACCCGGCCGAGCACGACCCGTACGAGACGTCGGTGGTCTTCGGCAGCGGCTCGGGGGGCAACGACTTCGGCCAGCGGGAGCTGTCCCGGCTGTGGACGCGGGGGCGCACCGCGGTCAGCGTCTACCAGTCGATCGCCTGGTTCTACGCGGCGACGACCGGCCAGACCTCGATCCGGCACGGGCTCAAGGGCCCGTCGGGCGTCCTCGTCTCCGACGGCGCCGGCGGCGTCGACAGCCTCGCCCAGGCCCGGCGGACCATCCGGCGCGGCACCCCCACGGTGCTCGCCGGCGGCGCCGAGTGCGGGCTGACGCCGTACGCGCTGACCTGCCACCTCAGCAGCGGCCGGGTCAGCTCCGCGGCGAGCCCCGCGGACGGCTACAAGCCGTTCGACGTCCGCGCCAACGGTTACCTGCCCGGTGAGGGCGGGGCGACCCTGCTCGTCGAGGACCCGGCTGCCGCGGCCCGCCGCGGCGCCCGCGTCTACGGCGAGATCGCCGGCTACGCGGCCACCCACGACGGCGCGCACCACGAGCAGGCGCCGGCGGACTCGCGCTGGCTGGCCGCGGCGATGCGCCGCGCGCTCGCCGACGCGGAGCTCACCCCCGCCGACGTCGACGTCGTGTTCGCCGACGGCGCCGGCTCCCCGGACCTCGACGCGCTGGAGGCGGAGGCCATCCGGGCCGTCTTCGGCGCCGGAGCGGTGCCCGTCACCGCCCCGCAGGGGCTCATCGGACGGCTGTGCGCCGGCGGCTCCGCCCTCGCCGCGGCGACCGCGCTGCTGTCGATCCGCGACGGGGTGATCCCCGCCGTGGGCAACCTCGACGAGCCCGACCCCGCCCACGGCCTCGACCTGGTGCGCTCGCCGCGTGAGGGCCGTGTCCGGGCCGCGCTGGTCAACGCGCGCGGCCACGGCGGGTTCAACAGCTCGCTCGTCCTGCGGGCGGTCGACACCGACTGA	MTVLDTAPSGTAGPARPAAGAVRPVITGLGVIAPSGVGLDAYWASTLRGELRVAPITRFDASRYDTRIAGEVPDFAAEEFVDHRYLVQTDRWTWMGMAASKLALADAAYDPAEHDPYETSVVFGSGSGGNDFGQRELSRLWTRGRTAVSVYQSIAWFYAATTGQTSIRHGLKGPSGVLVSDGAGGVDSLAQARRTIRRGTPTVLAGGAECGLTPYALTCHLSSGRVSSAASPADGYKPFDVRANGYLPGEGGATLLVEDPAAAARRGARVYGEIAGYAATHDGAHHEQAPADSRWLAAAMRRALADAELTPADVDVVFADGAGSPDLDALEAEAIRAVFGAGAVPVTAPQGLIGRLCAGGSALAAATALLSIRDGVIPAVGNLDEPDPAHGLDLVRSPREGRVRAALVNARGHGGFNSSLVLRAVDTD	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	102.88	gnl|BL_ORD_ID|1968|hsp_num:0	1943			84	1239	isoniazid
BGC0001197.1|Frankiamicin_12 # 11053 # 11790 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.724	BGC0001197.1|Frankiamicin_12 	11053	11790	+	Loose	450	54.6842	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	26.46	3004045	protein variant model	F203A	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	ATGTTCCCAGACCTGGCCGGCAAGCGTGCCCTGGTCACCGGCGGCACGCGCGGTATCGGCCGGGCCGTCGTGCTCGGGCTCGCCCAGGCCGGCGCCACCGTCGTGGTCGGCCACCAGCGCCAGACCGAGGACGCCGAGAGCCTGCGCCGCGAGCTCAAGGACACCGGCAACGATCACCTGCTGGTGCAGGCCGACGTCGCCGACCCGGCGCAGATCACCGAGCTGGTGTCGGCGACCGGCACCCACCTCGGCGGCCTCGACATCGTCGTGAACAGCGTCGGGACGATCAGCCACATCCCGTACGCCGACCTGCCGCTGGACGCCTGGACGCAGGTGCTGACCACCAACCTGACCGCGACCCACCTCGTCACCCAGGGTGCGCTGCCGCTGCTCGGCGACTCCGGGACGGTCGTCAACATCGGGTCCGGCGCCGGGCTCGTCGGCGTGCCGCTGCGCGCCCACTACACGGCGGCCAAGACGGGCCTGATCGGCCTCACCCGCTCGCTGTCCAAGGAGCTCGGCTCCAAGGGCATCCGGGTGAACCTGGTCTCGCCGGGCGTCATCGAGACCGACCAGGCGGCCGGCATGCCCCCGGCGGCGCGCGCCGCGTACACCAACCGCATCCCGCTGGGCCGGCTCGGCGAGGCCAACGAGGTCGCCGCCGTCGTCCTGTTCCTCGCCAGCGACGTGTCCAGCTACGTCAACGGCGCCACCTTCACGGTCGACGGAGGAATCTGA	MFPDLAGKRALVTGGTRGIGRAVVLGLAQAGATVVVGHQRQTEDAESLRRELKDTGNDHLLVQADVADPAQITELVSATGTHLGGLDIVVNSVGTISHIPYADLPLDAWTQVLTTNLTATHLVTQGALPLLGDSGTVVNIGSGAGLVGVPLRAHYTAAKTGLIGLTRSLSKELGSKGIRVNLVSPGVIETDQAAGMPPAARAAYTNRIPLGRLGEANEVAAVVLFLASDVSSYVNGATFTVDGGI	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	93.51	gnl|BL_ORD_ID|4712|hsp_num:0	2666			9	753	triclosan
BGC0001197.1|Frankiamicin_13 # 11790 # 12113 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.688	BGC0001197.1|Frankiamicin_13 	11790	12113	+	Loose	950	23.483	tcr3	31.25	3002893	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGGCCACCCCCAGCCGTTCCGCATCATGCTGACCATGCACATCCACCCGGGCCGCGAGCAGGAGTTCGAGCAGACCTGGCTGCGGATCGGGGACGGCGTGACCAGCCACCCGGCGAACCTCGGCCAGTGGCTGATCCGCTCCGAGGACGAGCCGAGCACGTACTACATCATCAGCGACTGGGTGGACGAGCCGAAGTTCCGCGAGTTCGAGCTGAGCCCCGGGCACCTGGAGCACCGCAAGATCCTCCACCCCCTGCGGGCCAGCGGCTCGATGGTCACCGGGACCGTGCTCACCCACCTTGTCGGCGCGGCGGCCGAGTGA	MGHPQPFRIMLTMHIHPGREQEFEQTWLRIGDGVTSHPANLGQWLIRSEDEPSTYYIISDWVDEPKFREFELSPGHLEHRKILHPLRASGSMVTGTVLTHLVGAAAE	MGMANATSQTGEAVADEAGGPAGFTHRQIITALSGLLLAVLLAALDQTIVSTALRTIGDQLHGQTVQAWVITGYLVSSTIAMPFYGKLSDIYGRKPLYLAAIAVFIVGSAACAMANSMETLAIARVLQGFGGAGLMSLPTAVIADLAPVRERGRYFSYLMMAWVAASVLGPLVGGLFAGAGEILGVTGWRWAFLINVPLGLVALLSVRKALNLPHRRVDHPIDFRGALTLALCLVPLLIVAEEGLDWGWGSARSLTLFAVSLIGLVLFVLAERARGLEAMVPLRLFRRGGITMATAVNFTIGVGIFGTVSTLPLFLQLVQGRSATVAGLVIIPVMTGAIVSQTICAKIIKKWNRYKKPAIVGLGSMAGALLSLSAAGADTPLAVIVVIAAWLGFGIGLSQTVITLAIQSSAPKSELGVANAASGLFRQLGGTSGAAVFMSVLFGVAAGRLDGADPDEAVRRALSDPGSTGGLSASAVDAFTSGFDTMFLVGGLILAVGFLLTFPLRELRDEE	20.90	gnl|BL_ORD_ID|592|hsp_num:0	652			633	729	tetracycline
BGC0001197.1|Frankiamicin_14 # 12110 # 12679 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=3-4bp;gc_cont=0.737	BGC0001197.1|Frankiamicin_14 	12110	12679	+	Loose	700	25.409	vanS gene in vanM cluster	32.65	3002939	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	GTGATCCGCCGCAAGAAGAAGGCGGATGCCCCGCCGGAGACCGACCCGCAGGAGACCGCCTCAGCGGAGTCGGCTCCAGCGGAGTCGGCCGCTGCGGAGTCGGCGACCGCGGAGCCGGCTGTGGCCGAGTCGTCCACTGGCGAGTCGGCTGTTGCCGGGTCGCCCGCGTCCGGCCCGGTCGAGGTCGAGGCCGAGGCCGAGGTCGAGGCCGAGGTCGAGGCTGAGGCCGGTGACGGTGGCCGGGTGCGGGTGATGCTGTGGGCGGTCGACCCGGCCGAGGATCAGGGCGCGGTCGAGCGGGCCTACCACGAGATCAGCTCCAAGCTGGTGGGCACGCCCGGCCTGCTCGGGAACCGCCTGCTGCGCTCCGCCGCCGAGCCGACGAAGTTCGCCGTCGTCAGCGAGTGGGCGAGCATGGCCGAGTTCGTGACCTGGGAACGCGGGGCGGACCACAAGCCGGCCACCTCGCCGCTGCGTCCGCTGCAGGACCCGGCGATGCGCGCGACCATCTTCACCGAGGTCGCCGCCTACGGCCCGGACGGCCCCTTCACCGAGCCGGACGGATTCTGA	MIRRKKKADAPPETDPQETASAESAPAESAAAESATAEPAVAESSTGESAVAGSPASGPVEVEAEAEVEAEVEAEAGDGGRVRVMLWAVDPAEDQGAVERAYHEISSKLVGTPGLLGNRLLRSAAEPTKFAVVSEWASMAEFVTWERGADHKPATSPLRPLQDPAMRATIFTEVAAYGPDGPFTEPDGF	MAKMRSSFRTKIILLFAVSMLLAGMVTYLLFKGLQLYYHTMIHRGNPLAELRDFIESIGDFNFFFLLFILLSLSVFYILTKPYSAYFDEISTGIQYLALGDFKRRVNIQSNDEFGDIAQAINQASEKLEEAIQRGDFSENSKEQLVVNLAHDLRTPLTSVLGYLDLVLKDEKLTKEQVRHFLTIAFTKSQRLEKLIDELFEITRMNYGMLSIEKKPINLTDLLLQLKEELYPIFEKNGLTARMNTLPHLPVSADGEMLARVFENLLTNANRYGHDGQFVDINGFVDEEEVVVQVVNYGDSIPPNELPYLFDMFYTGDKARTHKEDSTGLGLFIAKNIVEQHNGTVTAESSLIRTVFEVRLPLESAPIDQV	51.08	gnl|BL_ORD_ID|4739|hsp_num:0	1328			705	852	vancomycin; teicoplanin
BGC0001197.1|Frankiamicin_10 # 8315 # 9667 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.731	BGC0001197.1|Frankiamicin_10 	8315	9667	+	Loose	750	197.593	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	35.61	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGAGCAAACCCACGCAGCGGTCGCGGCCGGACGACGCTCACGGGCCGGCGTCACGGGACGGGGGTCCGCGCCGCACCGCGGTGACCGGGGTCGGCGTCGTCGCCCCCGGTGGCTCGAACCGCAAAGAGTTCTGGACCCTGCTCACAGACGGCCGCACCGCCACCCGCCGGCTGTCCTTCTTCGACCCGTCGCCGTTCCGGTCGCAGGTCGCGGCCGAGTGCGACTTCGACCCGCTCGCCGCCGGCCTCACCCGCCAGGAGATCGCGCGCAACGACCGGTTCGTGCAGTTCGCGCTGGCCGCGGCCGCGGAGGCGGTGGCCGACAGCGGGTTGGACCTCGGCCTCGGTGTCGGCGGCACCGAACGCGAGCCGGGCGACGGGCCGGTCGTCGGGGTGAGCATGGGCAGCGCCGTCGGGGCGACCACCCGGCTCGAGAACGAGTACGTGGTCGTCAGCGACGGCGGGAAGCACTGGGAGGTCGACCCGCGCTACGCGAGCTCGTTCCTCTACCACGCGCTCGTGCCGAGCTGCCTGGCCACCGAGATCGCCTGCCGCTTCGGCGCGCACGGCCCGTCGTTCGTGGTCTCCACCGGGTGCACCTCCGGCATCGACGCGGTCGGCTACGGCCACCAGCTCATCGTCGACGGCGAGGCGGACATCGTGATCGCCGGCGCCTCCGACGCGCCGCTCTCGCCGATCTCCATCGCCTGCTTCGACGCCATCCGCGCCACCTCGGCCCGCAACGACGACCCCGAGCACGCCTCGCGGCCGTTCGACGCCAGCCGCGACGGCTTCGTGATGGGGGAGGGCAGCGCCGTGCTGATCCTCGAGGAGCTGGAGTCGGCCCGGGCCCGCGGCGCGCACATCTACTGCGAGGTCGGCGGGTACGCCTCGCGGTCCAACGCTTTCCACATGACCGGCCTGCGCCCGGACGGCGTCGAGATGGCCGAGGCCATCCGCATCGCCCTGGACCAGGCGCGGCTCGACCCGTCCGCCGTCGACTACGTCAACGCCCACGGGTCGGGGACGAAGCAGAACGACCGGCACGAGACGGCCGCTTTCAAACGGTCGCTGGGCGCCCACGCCCACGAGGTGCCGGTCAGCTCGATCAAGTCGATGGTCGGCCACTCCCTCGGCGCGATCGGCTCCATCGAGCTCGCGGCCTGCGCGCTGGCGATCGAGCACAACGTGGTGCCGCCGACGGCGAACTGGTCGACCCGCGACCCCGAGTGCGACCTGGACTACGTCCCGAACACCGCCCGCGACCACACGGTGGACGCGGCGCTGTCGGTCGGCAGCGGGTTCGGCGGGTTCCAGTCGGCCATCGTCCTGACCTCGGCGGACCGGGCATGA	MSKPTQRSRPDDAHGPASRDGGPRRTAVTGVGVVAPGGSNRKEFWTLLTDGRTATRRLSFFDPSPFRSQVAAECDFDPLAAGLTRQEIARNDRFVQFALAAAAEAVADSGLDLGLGVGGTEREPGDGPVVGVSMGSAVGATTRLENEYVVVSDGGKHWEVDPRYASSFLYHALVPSCLATEIACRFGAHGPSFVVSTGCTSGIDAVGYGHQLIVDGEADIVIAGASDAPLSPISIACFDAIRATSARNDDPEHASRPFDASRDGFVMGEGSAVLILEELESARARGAHIYCEVGGYASRSNAFHMTGLRPDGVEMAEAIRIALDQARLDPSAVDYVNAHGSGTKQNDRHETAAFKRSLGAHAHEVPVSSIKSMVGHSLGAIGSIELAACALAIEHNVVPPTANWSTRDPECDLDYVPNTARDHTVDAALSVGSGFGGFQSAIVLTSADRA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	108.17	gnl|BL_ORD_ID|1968|hsp_num:0	1943			255	1239	isoniazid
